π23 centres are now opened to recruitment in France, The UK, Germany, the Czech Republic, Spain and the Netherlands.π₯ 2 additional sites will follow at the beginning of 2026.π©ββοΈ About 180 patients have been recruited so far in the trial, and a strong effort is being...
Regulatory approval has now been obtained for all participating coutries.βοΈ Since the beginning of the RITA-MI2 trial in 2022, 20 recruitment centres, in France, the UK, Germany, Spain and the Czech Republic have opened for recruitment. π 4 additional centres, in...